North East ERDF Innovation Fund triples stake in Nunabio Limited
Published
Nunabio Limited, a Newcastle Upon Tyne-based biotechnology firm founded in 2012, recorded changes to its cap table according to its latest confirmation statement for the period ending 6 June 2026. The primary change involves The North East (ERDF) Innovation Fund Limited Partnership, acting through Innovation GP Limited, which increased its holding by 204 percent. The fund now holds 282,896 A Ordinary shares, up from 93,063.
Several new investors joined the cap table during this period. Mason Capital Investments Ltd entered with 59,600 Ordinary shares, while NAVG GP LLP, acting for the North East Spinout Inspire Fund LP, took a position of 51,493 A Ordinary shares. Maven NPIF II NE Equity GP Limited also joined with 25,747 shares. Other new entrants include Alderley Park Ventures Limited and BioCity Investments Limited, each holding 10,299 A Ordinary shares. Alderley Park Ventures is also a shareholder in Nanosyrinx Ltd, while BioCity Investments backs Enterobiotix Limited. PJ Fitzpatrick Executive Advisory Group, LLC rounded out the new additions with 2,005 shares.
The arrival of multiple institutional and regional investors may signal a recent round of investment. These new shareholders join existing backers including MNL (Ascension) Nominees Limited on behalf of Ascension Ventures, which holds 153,986 shares, and Newcastle University Holdings Limited with 95,300 shares. Martlet Capital Limited and WCS Nominees Ltd both maintain holdings of 74,450 shares. Nunabio manufactures synthetic DNA and provides cell free DNA solutions for biotechnology researchers and manufacturers.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | MASON CAPITAL INVESTMENTS LTD | 59,600 | — | ORDINARY 59,600 |
| New shareholder | NAVG GP LLP (ACTING AS GENERAL PARTNER OF THE NORTH EAST SPINOUT INSPIRE FUND LP) | 51,493 | — | A ORDINARY 51,493 |
| New shareholder | MAVEN NPIF II NE EQUITY GP LIMITED, AS GENERAL PARTNER OF NPIF II EQUITY NE LP | 25,747 | — | A ORDINARY 25,747 |
| New shareholder | ALDERLEY PARK VENTURES LIMITED | 10,299 | — | A ORDINARY 10,299 |
| New shareholder | BIOCITY INVESTMENTS LIMITED | 10,299 | — | A ORDINARY 10,299 |
| New shareholder | PJ FITZPATRICK EXECUTIVE ADVISORY GROUP, LLC | 2,005 | — | A ORDINARY 2,005 |
| Increased | THE NORTH EAST (ERDF) INNOVATION FUND LIMITED PARTNERSHIP - ACTING THROUGH INNOVATION GP LIMITED | 282,896 | +204% | A ORDINARY 282,896 |
Current shareholders (13)
| Shareholder | Total shares | Share classes |
|---|---|---|
| THE NORTH EAST (ERDF) INNOVATION FUND LIMITED PARTNERSHIP - ACTING THROUGH INNOVATION GP LIMITED | 282,896 | A ORDINARY 282,896 |
| MNL (ASCENSION) NOMINEES LIMITED ON BEHALF OF ASCENSION VENTURES | 183,852 | A ORDINARY 72,178 ORDINARY 111,674 |
| NEWCASTLE UNIVERSITY HOLDINGS LIMITED | 95,300 | ORDINARY 95,300 |
| WCS NOMINEES LTD ON BEHALF OF THE INVESTORS IN PIONEER LIFE SCIENCES EIS KNOWLEDGE INTENSIVE FUND | 90,056 | A ORDINARY 74,450 ORDINARY 15,606 |
| MARTLET CAPITAL LIMITED | 74,450 | A ORDINARY 74,450 |
| MASON CAPITAL INVESTMENTS LTD | 59,600 | ORDINARY 59,600 |
| NAVG GP LLP (ACTING AS GENERAL PARTNER OF THE NORTH EAST SPINOUT INSPIRE FUND LP) | 51,493 | A ORDINARY 51,493 |
| NORTHSTAR NOMINEES LIMITED | 30,895 | A ORDINARY 30,895 |
| MARA NOMINEES LIMITED | 29,866 | A ORDINARY 29,866 |
| MAVEN NPIF II NE EQUITY GP LIMITED, AS GENERAL PARTNER OF NPIF II EQUITY NE LP | 25,747 | A ORDINARY 25,747 |
| ALDERLEY PARK VENTURES LIMITED | 10,299 | A ORDINARY 10,299 |
| BIOCITY INVESTMENTS LIMITED | 10,299 | A ORDINARY 10,299 |
| PJ FITZPATRICK EXECUTIVE ADVISORY GROUP, LLC | 2,005 | A ORDINARY 2,005 |
Contact the editorial team at [email protected]